Welcome to our dedicated page for Piper Sandler Co`S news (Ticker: PIPR), a resource for investors and traders seeking the latest updates and insights on Piper Sandler Co`S stock.
Piper Sandler Companies reports news on its investment banking and institutional securities business, including advisory services, equity and debt capital markets, public finance, institutional brokerage, research, fixed income, and alternative asset management activities. Coverage commonly includes financial results, dividends, capital actions, and updates to teams serving corporate, private equity, public entity, nonprofit, and institutional investor clients.
Company announcements also cover platform expansion in areas such as distressed debt, special assets, healthcare investment banking, life sciences outsourcing, B2B med tech, and fixed income. Governance-related news includes board appointments and other corporate updates tied to the firm’s public-company structure.
Piper Sandler & Co. has acted as the financial advisor for Platinum Equity in acquiring Solenis for an enterprise value of $5.25 billion. The acquisition involves merging Solenis with Sigura Water, another Platinum Equity portfolio company, for a total transaction value of approximately $6.5 billion. The combined company is projected to generate $3.5 billion in revenue, targeting diverse markets in water treatment. Completion of the acquisition is expected by the end of 2021, pending regulatory approvals.
Piper Sandler Companies (NYSE: PIPR) has expanded its special district group in Denver with the addition of Matt Chorske and Shane Miner. Chorske, with over 23 years in special district banking, and Miner, who has 15 years of experience, both previously worked at BBVA USA Bancshares. The firm has seen significant growth in this sector since launching the special district group in November 2020, now boasting over 20 professionals. This strategic expansion aims to enhance service and expertise for clients in public finance.
Piper Sandler advised SK Capital Partners on the sale of Niacet Corporation to Kerry Group plc for $1.015 billion on a cash-free, debt-free basis. The acquisition will enhance Kerry’s food protection and preservation platform. Niacet is recognized for its leadership in Bakery and Pharma sectors, offering low-sodium preservation technologies for Meat and plant-based foods. The transaction is expected to close by Q3 2021, pending regulatory approvals. SK Capital's portfolio generates around $11 billion annually and employs over 16,000 people globally.
EverArc Holdings has announced its acquisition of 100% of Perimeter Solutions from SK Capital for approximately $2 billion, comprising cash and preferred shares. This transaction is expected to close in Q4 2021 and is subject to customary closing conditions. Perimeter Solutions specializes in high-quality firefighting products and lubricant additives, contributing significant market presence in both sectors. The acquisition aims to enhance EverArc's portfolio in these essential industries.
Piper Sandler has advised Heubach Group, alongside SK Capital Partners, in acquiring Clariant’s Pigments Business for approximately CHF 805 million, with a potential additional CHF 50 million tied to 2021 performance. This acquisition is expected to create a global leader in pigments with annual sales exceeding €900 million. Clariant will reinvest for an ownership stake to support the combined entity's growth. The deal is subject to customary approvals and is anticipated to close in the first half of 2022.
Piper Sandler Companies (NYSE: PIPR) announced the appointment of Jeffrey Thomas as a managing director in its healthcare investment banking group, focusing on MedTech and life sciences. With over 20 years of experience, Thomas previously served as chief corporate development officer at Laborie, involved in global strategy and M&A. His background includes executive roles at Smith & Nephew and GE Healthcare, and academic positions in medical research. This addition aims to strengthen Piper Sandler's capabilities in the healthcare sectors.
Piper Sandler Companies (NYSE: PIPR) has appointed Austin Harbour as a managing director in their energy and power investment banking group, focusing on oilfield services and equipment. With over 10 years of sector experience, Harbour previously held roles at Superior Energy Services and Lazard Freres. This addition aims to enhance client services, complementing the recent hiring of Robert Sternthal to expand the renewables platform. The energy and power team now includes 19 managing directors, reinforcing Piper Sandler's commitment to growth in the energy sector.
Piper Sandler (NYSE: PIPR) announces the addition of Rob Sternthal as a managing director in its energy and power investment banking group, based in New York. Sternthal brings over 20 years of experience, previously leading North American renewable energy at Rubicon Capital Advisors and holding senior roles at Credit Suisse. His expertise is expected to enhance client services in M&A advisory, capital markets, and investment research within the renewable sector.
Piper Sandler Companies (NYSE: PIPR) has appointed Chris O’Brien as a managing director in its technology investment banking group, focusing on industrial software and technology. O’Brien brings 16 years of relevant experience, having previously led the industrial software sector at KeyBanc Capital Markets. His addition aligns with Piper Sandler's growth strategy in the technology sector, which includes a wide array of advisory services across various tech domains. The firm anticipates further market share gains due to its comprehensive offerings in equity and debt capital markets.
Piper Sandler Companies (NYSE: PIPR) has appointed Richard Singh as a managing director in its healthcare investment banking group, based in London. Singh previously led healthcare advisory efforts at Gleacher Shacklock LLP and held a managing director role at Citigroup. His addition aligns with Piper Sandler's strategy to enhance its healthcare investment banking operations in Europe. Singh joins Vincenzo di Nicola to expand global outsourcing pharma coverage, aiming to deliver growth opportunities and maximize shareholder value.